GlassScriptPhysician profile
Michael A Schwartz
NPI 1093767675
$6,114.75
in general payments reported to CMS, 2019-2025
14 companies · $640 in 2025
The $640 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,689 · 2020: $40.27 · 2021: $2,079 · 2022: $547 · 2023: $376 · 2024: $743 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,758.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,890.41 | 2019-2021 | |
| Stryker Corporation | $1,208.49 | 2019-2025 | Axsos, Variax, Gamma |
| Gotham Surgical Solutions & Devices, INC. | $815.35 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $408.67 | 2024-2025 | Comprehensive Shoulder System, Arcos |
| Pfizer INC. | $258.28 | 2019-2024 | |
| Vericel Corporation | $161.96 | 2024-2025 | Maci |
| Smith+Nephew, INC. | $140.92 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Bioventus LLC | $77.49 | 2023-2024 | Durolane, Exogen Ultrasound Bone Healing System |
| Trice Medical, INC. | $38.71 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $26.68 | 2022 | |
| Janssen Pharmaceuticals, INC | $25.25 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.22 | 2020 | |
| Depuy Synthes Sales INC. | $22.10 | 2022 | |
| Checkpoint Surgical, INC | $18.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.